Envveno Medical Nails It: Final Implants in Pre-Clinical GLP Study are a Resounding Success!
Successful Completion of All Planned Implants in GLP Study Marks Major Milestone for enVVeno Medical Corporation A Game-Changer in Venous Disease Treatment Today, enVVeno Medical Corporation (Nasdaq:NVNO) is celebrating a significant achievement in the field of venous disease treatment. The successful completion of the final wave of implants for shorter-term subjects in its six-month pre-clinical…